Lucia MS, Epstein JI, Goodman PJ, Darke AK, Reuter VE, Civantos F, Tangen CM, Parnes HL, Lippman SM, La Rosa FG, Kattan MW, Crawford ED, Ford LG, Coltman CA, Thompson IM
By monitoring Loss of Exclusivity (LOE) forecasts and performing white space analysis, facilities can identify therapeutic areas with high demand but low patent density, or identify when specific formulation patents expire, allowing for the legal production of non-infringing compounds
Abstract Alpha-lipoic acid is an organic, sulfate-based compound produced by plants, humans, and animals
SNO-MLP (S-Nitrosylation of Muscle LIM Protein) facilitates myocardial hypertrophy through TLR3 (Toll-Like Receptor 3)-mediated RIP3 (Receptor-Interacting Protein Kinase 3) and NLRP3 (NOD-Like Receptor Pyrin Domain Containing 3) inflammasome activation
Notably, studies have shown significant body weight reduction, improved glycemic control and better metabolic health